Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/13/2008

- Annual Xyrem(R) Net Sales Increase 34 Percent

- Investor Day Scheduled for March 13, 2008

PALO ALTO, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced financial results for the fourth quarter and full year ended December 31, 2007.

Total revenues for the quarter ended December 31, 2007 were $15.5 million, compared to $12.4 million for the quarter ended December 31, 2006. Total revenues for the year ended December 31, 2007 increased 46 percent to $65.3 million, compared to $44.9 million for the year ended December 31, 2006. Xyrem(R) (sodium oxybate oral solution) net sales for the quarter ended December 31, 2007 increased 38 percent to $11.1 million, compared with $8.1 million for the last quarter of 2006. Xyrem net sales for the year ended December 31, 2007 increased 34 percent to $39.0 million, compared with $29.0 million for the year ended December 31, 2006.

"We are very pleased with the momentum we achieved in 2007. Our focus in 2008 will be on execution, including the planned commercial launch of LUVOX(R) CR in the first quarter of 2008 after anticipated FDA approval," said Samuel R. Saks, M.D., Chief Executive Officer. "Our portfolio of development-stage product candidates is making steady progress, and we believe that our development efforts will lead to important new products for patients and caregivers."

Jazz Pharmaceuticals' net loss for the fourth quarter of 2007 was $60.0 million, compared to a net loss of $20.5 million for the fourth quarter of 2006. For the year ended December 31, 2007, the company's net loss was $138.8 million, compared to a net loss of $59.4 million for the year ended December 31, 2006. Net loss for th
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
2. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
3. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
4. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
5. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
6. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
7. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
8. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
9. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
11. Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Though health care jobs continued to ... Bureau of Labor Statistics -- the increase was far below ... new health care jobs were added in home health care ... of 6,000 jobs. Overall, the U.S. unemployment rate stayed flat ... Christmas reported that a total of just over 36,000 job ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 New user ... Saniclave 200 prevent the dangers of misuse and ... like knobs, analog pressure gauges, hot surfaces and complex ... or a new, modern autoclave, Revolutionary Science explains some ... water. Older autoclave designs will recycle dirty water. ...
(Date:6/18/2013)... Earlier this year, Google announced the new ‘enhanced campaign’ ... impacts the core component of the product, the campaign, many ... updates since its inception in October of 2000. The ... very informative article on the subject.. , Google ... enhanced campaigns . Only recently, a date of July ...
(Date:6/18/2013)... Washington DC (PRWEB) June 18, 2013 ... Medicaid Services (CMS) released a final decision memorandum ... covered to guide subsequent management of anti-tumor strategy, ... data collection. The National Oncological PET Registry (NOPR) was ... of the first projects under the Coverage with Evidence ...
Breaking Biology Technology:MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 2Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 3WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3
... ) today reported results for the third quarter ended September,30, ... per share, for,the third quarter 2007, from a net loss ... 2006. Cash and short-term investments totaled,$13.9 million at September 30, ... quarter 2007 is due to a 21%,decrease in operating expenses ...
... Reports Results for the Nine Month Period Ended September ... ... results for the nine month period ended September 30, 2007,as follows: Revenues ... September 30, 2007. In the same period of 2006, Genmab,recognised DKK 105.6 million ...
... ANN ARBOR, Mich., Oct. 30 NanoBio(R) ... commercializing novel,products for the prevention and treatment ... Joyce Sutcliffe, Ph.D., as vice president of,research. ... in the discovery and design of,new antibiotics, ...
Cached Biology Technology:Pharmos Corporation Reports 2007 Third Quarter Results 2Pharmos Corporation Reports 2007 Third Quarter Results 3Pharmos Corporation Reports 2007 Third Quarter Results 4Pharmos Corporation Reports 2007 Third Quarter Results 5Genmab Announces Results for the First Nine Months of 2007 2Genmab Announces Results for the First Nine Months of 2007 3Genmab Announces Results for the First Nine Months of 2007 4Dr. Joyce Sutcliffe Joins the NanoBio Team as Vice President of Research 2
(Date:6/18/2013)... of Medicine have discovered a mechanism that is used ... component of blood typically associated with clotting, were discovered ... seal it off from the rest of the body. ... this week, provide the science community with a ... known that platelets do participate in immunity, but now ...
(Date:6/18/2013)... from the United Kingdom, the Energy Department,s National ... Kentucky have recently published a paper describing a ... Limnoria quadripunctata , commonly known as the ... they exhibit a relatively unique ability to produce ... to break down the biomass they eat. New ...
(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... recently received two grants from the National Science ... on the Implications of Cutting-Edge Biotechnologies for Sustainability ... research on the use of on-line prediction markets ... The workshop will develop an EU-U.S. trans-disciplinary research ...
... Joseph, Michigan A new internet-based tool for designing ... and to optimize design by allowing rapid development of ... of Resource: Engineering & Technology for a Sustainable ... and Agricultural Engineering at the University of Missouri, introduces ...
... investigation an international body of earth scientists has formally agreed ... by 800,000 years, reports the Journal of Quaternary Science ... International Commission on Stratigraphy (ICS), the authority for geological science ... declaring when the Quaternary Period, which covers both the ice ...
Cached Biology News:Web-based innovation improves, eases agricultural terrace design 2End of an era: New ruling decides the boundaries of Earth's history 2
A Highly Purified, Cost-Effective Taq DNA Polymerase...
... DTNB , Ellman's reagent ... 69-78-3 *Storage: RT, When an enzyme-catalyzed ... not present in the substrate, it may be ... directly with the product to form a chromophore. ...
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... a recombinant human protein produced in E. coli ... RNase A type enzymes. The mode of ... in a 1:1 ratio. The enzyme has been ... and cell types. Addition of the ribonuclease inhibitor ...
Biology Products: